The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pilot Agreement

29 Jan 2021 07:00

RNS Number : 2791N
Catenae Innovation PLC
29 January 2021
 

29 January 2021

 

Catenae Innovation PLC

("Catenae", the "Company" or the "Group")

 

Catenae secures new pilot agreement for Covid-19 testing platform

 

Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, is pleased to announce that a Fortune 500 American professional services and construction company (the "Client") listed on the New York Stock Exchange is piloting the Company's Covid-19 testing platform across certain areas of its U.K. division.

 

Upon completion of a Covid-19 test supplied and administered by BHA-Medical Limited, Catenae will securely process the Client's employees' test results on its GDPR-compliant data management platform. The Company will send the test results to each employee by text message and email, and will also provide the Client with details of its employees' results in a daily report in a GDPR-compliant manner.

 

All results will be fed into Public Health England's database for use by the NHS' Test and Trace service.

 

The pilot commenced on 28 January 2021 and will run for the next 12 weeks until the end of April 2021. Although the pilot is not expected to generate substantial revenues for the Company, it endorses the Company's Covid-19 testing proposition.

 

Guy Meyer, Chief Executive Officer of Catenae, said: "It is a significant milestone for Catenae to be providing its data management platform as part of a Covid-19 testing trial to a global corporation of this calibre. Businesses fully appreciate that even though vaccines are a significant part of managing this pandemic, regular testing of their workforces helps mitigate the risks of infectious outbreaks that interrupt their operations and weaken business resilience.

 

"Our platform helps them maintain operational effectiveness as best they can in the current circumstances through having up-to-date test result information about the Covid-19 health status of their working populations wherever they are.

 

"The construction industry remains a key target for the Company as it is one of the critical infrastructure sectors that remains operational during the government lockdown. We look forward to updating the market on further progress in due course."

 

 

-Ends-

 

For further information please contact:

 

Catenae Innovation PLC

+44 (0)191 580 8545

Guy Meyer, Chief Executive Officer

 

Brandon Hill Capital Limited, Broker

+44 (0)20 3463 5000

Andy Gutmann

 

Yellow Jersey PR (PR & IP)

+44 (0)20 3004 9512

Sarah Hollins / Annabel Atkins / Matthew McHale

 

Notes to Editors:

 

About Catenae Innovation PLC

 

Catenae Innovation is an AIM quoted provider of digital media and technology services. Catenae use the power of blockchain to deliver solutions where its people-centric technology enables trust and certainty allowing organisations to gain better control over their operations, manage staff and safely welcome customers.

 

www.catenaeinnovation.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASEMFWAEFSEDF
Date   Source Headline
9th Feb 20242:44 pmRNSResult of AGM, Change of Name & RPT
17th Jan 20247:00 amRNSFurther re: Convertible Loan & Notice of AGM
4th Dec 20237:00 amRNSFurther re: Hyperneph, Insurance Policy and RPT
29th Sep 20237:00 amRNSHalf-year Report
31st Aug 20231:54 pmRNSRelated Party Transactions
22nd May 20237:00 amRNSFurther re: Hyperneph Software Limited
31st Mar 20232:04 pmRNSRelated Party Transactions
30th Mar 20233:56 pmRNSFinal Results
7th Mar 20237:00 amRNSChange of Accounting Reference Date
21st Feb 20232:11 pmRNSTrading Update
30th Sep 20227:30 amRNSRestoration - Catenae Innovation Plc
30th Sep 20227:00 amRNSHalf-year Report and Convertible Loan
30th Sep 20227:00 amRNSFinal Results
2nd Sep 202212:09 pmRNSCompany Update
30th Jun 20227:00 amRNSFinancial Information to 31 March 2022 and Update
30th May 20227:00 amRNSUpdate
17th May 20227:00 amRNSFurther re:- Hyperneph Software Limited
12th May 202210:07 amRNSHyperneph Software Limited Update
29th Apr 20227:00 amRNSFurther re:- Suspension of Trading on AIM
1st Apr 20227:30 amRNSSuspension - Catenae Innovation PLC
1st Apr 20227:00 amRNSSuspension of Trading on AIM
23rd Mar 20222:10 pmRNSTemporary Suspension and Update
8th Mar 20222:05 pmRNSSecond Price Monitoring Extn
8th Mar 20222:00 pmRNSPrice Monitoring Extension
1st Feb 20222:17 pmRNSExercise of Warrant
26th Jan 202210:10 amRNSExercise of Warrant
4th Jan 20227:00 amRNSChange of Broker
8th Dec 20214:41 pmRNSSecond Price Monitoring Extn
8th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Sep 20217:00 amRNSCatenae exhibits at UK Construction Week with CHL
15th Sep 20217:00 amRNSIssue of Equity / PDMR / Exercise of Warrants
9th Aug 20217:00 amRNSData Visualisation Order from SaxaVord Space Port
2nd Aug 20212:05 pmRNSSecond Price Monitoring Extn
2nd Aug 20212:00 pmRNSPrice Monitoring Extension
2nd Aug 20217:00 amRNSCollaboration agreement with ProMake Limited
27th Jul 20217:00 amRNSDirector and PDMR remuneration - Conversion
7th Jul 20217:00 amRNSPilot programme with a charity
30th Jun 20212:05 pmRNSSecond Price Monitoring Extn
30th Jun 20212:00 pmRNSPrice Monitoring Extension
30th Jun 20217:00 amRNSHalf Year Results to 31 March 2021
30th Jun 20217:00 amRNSFinal Results
4th May 20217:00 amRNSAcquisition of Hyperneph Software Limited
28th Apr 20216:14 pmRNSHolding(s) in Company
16th Apr 20213:47 pmRNSExercise of Warrant
12th Apr 202111:09 amRNSUpdate re Issue of Warrants
9th Apr 20214:40 pmRNSSecond Price Monitoring Extn
9th Apr 20214:35 pmRNSPrice Monitoring Extension
9th Apr 202111:05 amRNSSecond Price Monitoring Extn
9th Apr 202111:00 amRNSPrice Monitoring Extension
31st Mar 20212:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.